At Investor Conferences

Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Sotio Biotech a.s.

SOTIO is an international biotechnology company developing new medical therapies, focusing on the treatment of cancer and autoimmunity diseases. The company conducts research concerning the actual platform of active cellular immunotherapy on the basis of dendritic cells, with the goal of significantly improving this treatment and making it accessible to patients. In SOTIO’s laboratory in Prague, equipped with state-of-the-art technologies, leading scientists research the role of dendritic cells in the therapeutic activation of the immune system and work to verify its safety and efficacy through clinical trials. SOTIO has facilities in Europe, the United States, China and Russia. *

 

Period Start 2012-12-13 existent
  Group PPF Group (Group)
Products Industry BIOTECH
  Industry 2 drug discovery
Persons Person Špíšek, Radek (PPF Group 201803– CEO of Sotio + Prof at Charles Univ Prague)
  Person 2 Bartonícek, Ladislav (PPF Group 201502 Board Member responsible for biotechnology)
     
Region Region Praha (Prague)
  Country Czech Republic
  Street 1518/2 Jankovcova
  City 17000 Prague 7
    Address record changed: 2021-12-04
     
Basic data Employees n. a.
     
    * Document for �About Section�: PPF Group N.V.. (2/4/15). "Press Release: PPF Group Acquires a Minority Stake in Biotech Company Cytune Pharma in Cooperation with Sotio".
     
   
Record changed: 2021-12-05

Advertisement

Picture EBD Group BIO-Europe 2022 Leipzig 650x200px

More documents for PPF Group (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px




» top